{
    "nctId": "NCT02675049",
    "briefTitle": "Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia",
    "officialTitle": "Efficacy and Optimal Dose Selection of Intranasal Dexmedetomidine During Breast Lumpectomy Under Local Anaesthesia",
    "overallStatus": "COMPLETED",
    "conditions": "Intranasal Dexmedetomidine Breast Cancer Local Anaesthesia",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Sedation changes using the modified Observer's Assessment of Alertness/Sedation (OAA/S) scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* with ASA(American Society of Anesthesiologists) physical status I and II\n* scheduled for breast lumpectomy\n\nExclusion Criteria:\n\n* a history of heart block\n* upper respiratory tract infection\n* asthma\n* allergy to DEX or local anaesthetics\n* memory or cognitive dysfunction\n* pregnancy\n* lack of understanding the consent process\n* impaired liver or renal function\n* a history of drug or alcohol abuse",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}